RT Journal Article
SR Electronic
T1 Optimal timing for social distancing during an epidemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.30.20048132
DO 10.1101/2020.03.30.20048132
A1 Patterson-Lomba, Oscar
YR 2020
UL http://medrxiv.org/content/early/2020/04/01/2020.03.30.20048132.abstract
AB Social distancing is an effective way to contain the spread of a contagious disease, particularly when pharmacological interventions are not available. Conventional wisdom suggests that social distancing measures should be introduced as soon as possible after the beginning of an outbreak. Using a simple epidemiological model we show, however, that there is in fact an optimal time to initiate a temporal social distancing intervention if the goal is to reduce the final epidemic size or “flatten” the epidemic curve. The optimal timing depends strongly on the effective reproduction number (R0) of the disease, such that as the R0 increases, the optimal time decreases non-linearly. Additionally, if pharmacological interventions (e.g., a vaccine) become available at some point during the epidemic, the sooner these interventions become available the sooner social distancing should be initiated to maximize its effectiveness. Although based on a simple model, we hope that these insights inspire further investigations within the context of more complex and data-driven epidemiological models, and can ultimately help decision makers to improve temporal social distancing policies to mitigate the spread of epidemics.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementNo external funding was received for the present work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo empirical data was used in this manuscript. Results are based on analytical derivations and numerical simulations.